Browsing by Author "Earl, H. M."

Now showing items 1-1 of 1

Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trial.

Earl, H. M.; Hiller, L.; Howard, H. C.; Dunn, J. A.; Young, J.; Bowden, S. J.; McDermaid, M.; Waterhouse, A. K.; Wilson, G.; Agrawal, R.; O'Reilly, S.; Bowman, A.; Ritchie, D.M.; Goodman, Andrew; Hickish, T.; McAdam, K.; Cameron, D.; Dodwell, D.; Rea, D. W.; Caldas, C.; Provenzano, E.; Abraham, J. E.; Canney, P.; Crown, J. P.; Kennedy, M. J.; Coleman, R.; Leonard, R. C.; Carmichael, J. A.; Wardley, A. M.; Poole, C. J. (Elsevier, 2017-06)

The tAnGo trial was designed to investigate the potential role of gemcitabine when added to anthracycline and taxane-containing adjuvant chemotherapy for early breast cancer. When this study was developed, gemcitabine had ...